Generation of antibodies against prion protein in wild-type mice via helix 1 peptide immunization

Journal of Neuroimmunology

Volumn 144, Issue 1-2, 2003, Pages 38-45

  Arbel, Michal ^a   Lavie, Vered ^a   Solomon, Beka ^a  

^a TEL AVIV UNIVERSITY   (Israel)

Author keywords

Active immunization; Anti PrP antibodies; Helix 1; Prion protein

Indexed keywords

ANTIGEN; EPITOPE; HELIX 1 PEPTIDE ANTIGEN; PRION PROTEIN; PRION PROTEIN ANTIBODY; PROTEIN ANTIBODY; UNCLASSIFIED DRUG;

AMINO ACID SEQUENCE; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; BINDING AFFINITY; CONTROLLED STUDY; IMMUNIZATION; IMMUNOGENICITY; IMMUNOLOGICAL TOLERANCE; MOUSE; NONHUMAN; PEPTIDE ANALYSIS; PRION DISEASE; PRIORITY JOURNAL; PROTEIN CONFORMATION; WILD TYPE;

EID: 0142195845     PISSN: 01655728     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jneuroim.2003.08.036     Document Type: Article

References (27)

1. Barry R.A., Prusiner S.B. Monoclonal antibodies to the cellular and scrapie prion proteins. J. Infect. Dis. 154:1986;518-521.
2. Barry R.A., McKinley M.P., Bendheim P.E., Lewis G.K., DeArmond S.J., Prusiner S.B. Antibodies to the scrapie protein decorate prion rods. J. Immunol. 135:1985;603-613.
3. Barry R.A., Kent S.B., McKinley M.P., Meyer R.K., DeArmond S.J., Hood L.E., Prusiner S.B. Scrapie and cellular prion proteins share polypeptide epitopes. J. Infect. Dis. 153:1986;848-854.
4. Bastien N., Trudel M., Simard C. Protective immune responses induced by the immunization of mice with a recombinant bacteriophage displaying an epitope of the human respiratory syncytial virus. Virology. 234:1997;118-122.
5. Bendheim P.E., Barry R.A., DeArmond S.J., Stites D.P., Prusiner S.B. Antibodies to a scrapie prion protein. Nature. 310:1984;418-421.
6. Bode L., Pocchiari M., Gelderblom H., Diringer H. Characterization of antisera against scrapie-associated fibrils (SAF) from affected hamster and cross-reactivity with SAF from scrapie-affected mice and from patients with Creutzfeldt-Jakob disease. J. Gen. Virol. 66(Pt 11):1985;2471-2478.
7. Enari M., Flechsig E., Weissmann C. Scrapie prion protein accumulation by scrapie-infected neuroblastoma cells abrogated by exposure to a prion protein antibody. Proc. Natl. Acad. Sci. U. S. A. 98:2001;9295-9299.
8. Frenkel D., Balass M., Katchalski-Katzir E., Solomon B. High affinity binding of monoclonal antibodies to the sequential epitope EFRH of beta-amyloid peptide is essential for modulation of fibrillar aggregation. J. Neuroimmunol. 95:1999;136-142.
9. Gabizon R., McKinley M.P., Groth D., Prusiner S.B. Immunoaffinity purification and neutralization of scrapie prion infectivity. Proc. Natl. Acad. Sci. U. S. A. 85:1988;6617-6621.
10. Hanan E., Goren O., Eshkenazy M., Solomon B. Immunomodulation of the human prion peptide 106-126 aggregation. Biochem. Biophys. Res. Commun. 280:2001;115-120.
11. Hanan E., Priola S.A., Solomon B. Antiaggregating antibody raised against human PrP 106-126 recognizes pathological and normal isoforms of the whole prion protein. Cell Mol. Neurobiol. 21:2001;693-703.
12. Heppner F.L., Musahl C., Arrighi I., Klein M.A., Rulicke T., Oesch B., Zinkernagel R.M., Kalinke U., Aguzzi A. Prevention of scrapie pathogenesis by transgenic expression of anti-prion protein antibodies. Science. 294:2001;178-182.
13. James T.L., Liu H., Ulyanov N.B., Farr-Jones S., Zhang H., Donne D.G., Kaneko K., Groth D., Mehlhorn I., Prusiner S.B., Cohen F.E. Solution structure of a 142-residue recombinant prion protein corresponding to the infectious fragment of the scrapie isoform. Proc. Natl. Acad. Sci. U. S. A. 94:1997;10086-10091.
14. Kascsak R.J., Rubenstein R., Merz P.A., Tonna-DeMasi M., Fersko R., Carp R.I., Wisniewski H.M., Diringer H. Mouse polyclonal and monoclonal antibody to scrapie-associated fibril proteins. J. Virol. 61:1987;3688-3693.
15. Kasper K.C., Bowman K., Stites D.P., Prusiner S.B. Toward development of assays for scrapie-specific antibodies. Adv. Exp. Med. Biol. 134:1981;401-413.
16. Korth C., Stierli B., Streit P., Moser M., Schaller O., Fischer R., Schulz-Schaeffer W., Kretzschmar H., Raeber A., Braun U., Ehrensperger F., Hornemann S., Glockshuber R., Riek R., Billeter M., Wuthrich K., Oesch B. Prion (PrPSc)-specific epitope defined by a monoclonal antibody. Nature. 390:1997;74-77.
17. Meola A., Delmastro P., Monaci P., Luzzago A., Nicosia A., Felici F., Cortese R., Galfre G. Derivation of vaccines from mimotopes. Immunologic properties of human hepatitis B virus surface antigen mimotopes displayed on filamentous phage. J. Immunol. 154:1995;3162-3172.
18. Peretz D., Williamson R.A., Kaneko K., Vergara J., Leclerc E., Schmitt-Ulms G., Mehlhorn I.R., Legname G., Wormald M.R., Rudd P.M., Dwek R.A., Burton D.R., Prusiner S.B. Antibodies inhibit prion propagation and clear cell cultures of prion infectivity. Nature. 412:2001;739-743.
19. Riek R., Hornemann S., Wider G., Billeter M., Glockshuber R., Wuthrich K. NMR structure of the mouse prion protein domain PrP(121-321). Nature. 382:1996;180-182.
20. Schenk D., Barbour R., Dunn W., Gordon G., Grajeda H., Guido T., Hu K., Huang J., Johnson-Wood K., Khan K., Kholodenko D., Lee M., Liao Z., Lieberburg I., Motter R., Mutter L., Soriano F., Shopp G., Vasquez N., Vandevert C., Walker S., Wogulis M., Yednock T., Games D., Seubert P. Immunization with amyloid-beta attenuates alzheimer-disease-like pathology in the PDAPP mouse. Nature. 400:1999;173-177.
21. Scott M.R., Kohler R., Foster D., Prusiner S.B. Chimeric prion protein expression in cultured cells and transgenic mice. Protein Sci. 1:1992;986-997.
22. Sigurdsson E.M., Sy M.S., Li R., Scholtzova H., Kascsak R.J., Kascsak R., Carp R., Meeker H.C., Frangione B., Wisniewski T. Anti-prion antibodies for prophylaxis following prion exposure in mice. Neurosci. Lett. 336:2003;185-187.
23. Solomon B., Koppel R., Frankel D., Hanan-Aharon E. Disaggregation of alzheimer beta-amyloid by site-directed mAb. Proc. Natl. Acad. Sci. U. S. A. 94:1997;4109-4112.
24. Takahashi K., Shinagawa M., Doi S., Sasaki S., Goto H., Sato G. Purification of scrapie agent from infected animal brains and raising of antibodies to the purified fraction. Microbiol. Immunol. 30:1986;123-131.
25. White A.R., Enever P., Tayebi M., Mushens R., Linehan J., Brandner S., Anstee D., Collinge J., Hawke S. Monoclonal antibodies inhibit prion replication and delay the development of prion disease. Nature. 422:2003;80-83.
26. Wiley C.A., Burrola P.G., Buchmeier M.J., Wooddell M.K., Barry R.A., Prusiner S.B., Lampert P.W. Immuno-gold localization of prion filaments in scrapie-infected hamster brains. Lab. Invest. 57:1987;646-656.
27. Winklhofer K.F., Heske J., Heller U., Reintjes A., Muranyi W., Moarefi I., Tatzelt J. Determinants of the in vivo folding of the prion protein : a bipartite function of helix 1 in folding and aggregation. J. Biol. Chem. 278:2003;14961-14970.